Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 56 | 52 | −4 |
| Shares | 7.67M | 7.77M | +105.4K (+1.4%) |
| Value | $18.6M | $16.6M | −$1.92M (−10.3%) |
New holders (4)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| RBF Capital, LLC | 42,947 | $91.9K | 0.01% |
| SG Americas Securities, LLC | 23,446 | $50.0K | 0.00% |
| MAI Capital Management | 2,055 | $4.40K | 0.00% |
| First Horizon Advisors, Inc. | 1,750 | $3.75K | 0.00% |
Sold out (8)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Marquette Asset Management, LLC | 33,311 | $80.6K |
| Millennium Management LLC | 24,381 | $59.0K |
| World Equity Group, Inc. | 20,000 | $48.4K |
| Atria Investments LLC | 17,426 | $42.2K |
| Journey Strategic Wealth LLC | 12,489 | $30.2K |
| FMR LLC | 1,700 | $4.11K |
| Proequities, Inc. | 1,000 | $2.31K |
| Atala Financial Inc | 100 | $242 |